Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,685
Closed -$276K 1305
2025
Q4
$276K Buy
1,685
+144
+9% +$22.6K ﹤0.01% 1028
2025
Q3
$206K Sell
1,541
-3,491
-69% -$424K ﹤0.01% 1115
2025
Q2
$622K Sell
5,032
-33
-0.7% -$4.2K 0.01% 749
2025
Q1
$651K Buy
5,065
+3,353
+196% +$516K 0.01% 702
2024
Q4
$246K Buy
1,712
+49
+3% +$7.03K 0.01% 990
2024
Q3
$306K Buy
+1,663
New +$238K 0.01% 880
2024
Q2
Sell
-1,663
Closed -$306K 1167
2024
Q1
$306K Sell
1,663
-16
-1% -$3.05K 0.01% 878
2023
Q4
$302K Buy
1,679
+179
+12% +$27.9K 0.01% 869
2023
Q3
$239K Sell
1,500
-707
-32% -$116K 0.01% 875
2023
Q2
$312K Sell
2,207
-564
-20% -$90.4K 0.01% 780
2023
Q1
$467K Buy
2,771
+33
+1% +$5.89K 0.02% 669
2022
Q4
$464K Sell
2,738
-433
-14% -$78.5K 0.03% 596
2022
Q3
$593K Buy
3,171
+768
+32% +$162K 0.04% 454
2022
Q2
$390K Sell
2,403
-156
-6% -$24.7K 0.03% 551
2022
Q1
$481K Buy
2,559
+607
+31% +$115K 0.03% 475
2021
Q4
$517K Buy
1,952
+72
+4% +$19.4K 0.04% 401
2021
Q3
$543K Buy
1,880
+473
+34% +$121K 0.06% 346
2021
Q2
$281K Buy
+1,407
New +$273K 0.03% 456

Other funds holding RGEN

Ethic Inc's RGEN Position: Q1 2026 in Review

Ethic Inc sold out of Repligen (RGEN) in Q1 2026, closing a stake of 1,685 shares — an estimated $276K sold.

Ethic Inc first reported a position in RGEN in Q2 2021 and held it in 18 quarters. The position peaked at $651K in Q1 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Ethic Inc reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Ethic Inc sold 1,685 Repligen shares in Q1 2026, an estimated $276K.
  • Ethic Inc first reported a position in Repligen in Q2 2021 and held it in 18 quarters.
  • Ethic Inc's Repligen position peaked at $651K in Q1 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Ethic Inc's 13F filing for Q1 2026, filed 27 Apr 2026.